妊娠丢失组织染色体检测:一项荟萃分析
该荟萃分析纳入2000年以来55项研究,评估妊娠丢失组织染色体异常检出率及检测失败率。不同方法异常率25%-60%,散发与复发性流产异常率均为46%。鉴于异常率高但相同异常复发概率低,作者认为 routine 检测无临床获益,不推荐常规检测。
要点
- 不同检测方法染色体异常检出率差异大,SNP array最高60%,MLPA最低25%。
- 散发性和复发性妊娠丢失的染色体异常率均为46%,无差异。
- 因相同染色体异常复发概率低,常规检测妊娠丢失组织无临床获益。
核心结论
- 妊娠丢失组织染色体异常检出率高,但相同异常复发概率低,常规检测无临床获益,不推荐。
研究设计与样本
- 荟萃分析纳入2000年以来55项研究,分析妊娠丢失组织染色体异常检出率、检测失败率及各异常类型百分比。
主要发现
- aCGH检出染色体异常率为48%(95%CI 39-57),FISH为38%(95%CI 28-49),MLPA为25%(95%CI 12-42),SNP array为60%(95%CI 58-63),传统核型分析为47%(95%CI 43-51)。
- 散发性妊娠丢失染色体异常率为46%(95%CI 39-53),复发性为46%(95%CI 39-52),两者无差异。
关键数值与推荐
- 染色体异常检出率:aCGH 48%(95%CI 39-57),FISH 38%(95%CI 28-49),MLPA 25%(95%CI 12-42),SNP array 60%(95%CI 58-63),核型分析47%(95%CI 43-51)。
- 散发性与复发性妊娠丢失染色体异常率均为46%(95%CI 39-53 vs 39-52)。
临床怎么用
- 不推荐对妊娠丢失组织常规进行染色体异常检测,因检测结果不改变临床处理且无临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many clinics offer routine genetic testing of pregnancy loss tissue. This review presents a comprehensive literature search and meta-analysis on chromosomal abnormality rates of pregnancy loss tissue from women with a single or recurrent pregnancy loss. A total of 55 studies published since 2000 were included, analysed on the prevalence of test failure rates, abnormality detection rates and percentages of trisomy, monosomy X, structural abnormalities and other clinically (ir)relevant abnormalities detected by conventional karyotyping, array-comparative genomic hybridization (aCGH), single nucleotide polymorphism (SNP) array, fluorescence in-situ hybridization (FISH) and multiplex ligation-dependent probe amplification (MLPA). The detected prevalence of chromosomal abnormalities was 48% (95% confidence interval [CI] 39-57) using aCGH, 38% (95% CI 28-49) with FISH, 25% (95% CI 12-42) using MLPA, 60% (95% CI 58-63) using SNP array and 47% (95% CI 43-51) with conventional karyotyping. The percentage of detected abnormalities did not differ between women that suffered sporadic (46%; 95% CI 39-53) or recurrent (46%; 95% CI 39-52) pregnancy loss. In view of the high prevalence of chromosomal abnormalities in pregnancy loss tissue, and the low chance of recurrence of the same chromosomal aberration, it was concluded that detection of specific chromosomal abnormalities in pregnancy loss tissue has no clinical benefit. Therefore, routine testing of pregnancy loss tissue for chromosomal abnormalities is not recommended.
引用
- Smits MAJ, van Maarle M, Hamer G, et al. Cytogenetic testing of pregnancy loss tissue: a meta-analysis. Reprod Biomed Online. 2020. PMID: 32417200. doi:10.1016/j.rbmo.2020.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。